121 related articles for article (PubMed ID: 7503672)
1. The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1.
da Silva Cardoso M; Siemoneit K; Nemecek V; Epple S; Koerner K; Kubanek B
Arch Virol; 1995; 140(10):1705-13. PubMed ID: 7503672
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients.
Scarselli E; Cerino A; Esposito G; Silini E; Mondelli MU; Traboni C
J Virol; 1995 Jul; 69(7):4407-12. PubMed ID: 7539508
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation.
Mondelli MU; Cerino A; Lisa A; Brambilla S; Segagni L; Cividini A; Bissolati M; Missale G; Bellati G; Meola A; Bruniercole B; Nicosia A; Galfrè G; Silini E
Hepatology; 1999 Aug; 30(2):537-45. PubMed ID: 10421665
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies with broad specificity for hepatitis C virus hypervariable region 1 variants can recognize viral particles.
Cerino A; Meola A; Segagni L; Furione M; Marciano S; Triyatni M; Liang TJ; Nicosia A; Mondelli MU
J Immunol; 2001 Oct; 167(7):3878-86. PubMed ID: 11564805
[TBL] [Abstract][Full Text] [Related]
5. Experimental vaccine activities of recombinant E1 and E2 glycoproteins and hypervariable region 1 peptides of hepatitis C virus in chimpanzees.
Esumi M; Rikihisa T; Nishimura S; Goto J; Mizuno K; Zhou YH; Shikata T
Arch Virol; 1999; 144(5):973-80. PubMed ID: 10416378
[TBL] [Abstract][Full Text] [Related]
6. Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants.
Lesniewski RR; Boardway KM; Casey JM; Desai SM; Devare SG; Leung TK; Mushahwar IK
J Med Virol; 1993 Jun; 40(2):150-6. PubMed ID: 7689636
[TBL] [Abstract][Full Text] [Related]
7. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
8. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment.
Zibert A; Schreier E; Roggendorf M
Virology; 1995 Apr; 208(2):653-61. PubMed ID: 7538251
[TBL] [Abstract][Full Text] [Related]
9. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.
Kato N; Ootsuyama Y; Sekiya H; Ohkoshi S; Nakazawa T; Hijikata M; Shimotohno K
J Virol; 1994 Aug; 68(8):4776-84. PubMed ID: 7518526
[TBL] [Abstract][Full Text] [Related]
10. Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection.
Hjalmarsson S; Blomberg J; Grillner L; Pipkorn R; Allander T
J Med Virol; 2001 Jun; 64(2):117-24. PubMed ID: 11360243
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus.
Kato N; Sekiya H; Ootsuyama Y; Nakazawa T; Hijikata M; Ohkoshi S; Shimotohno K
J Virol; 1993 Jul; 67(7):3923-30. PubMed ID: 7685404
[TBL] [Abstract][Full Text] [Related]
12. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations of the putative envelope proteins encoding region of the hepatitis C virus in the progression to relapsed phase from acute hepatitis: humoral immune response to hypervariable region 1.
Sekiya H; Kato N; Ootsuyama Y; Nakazawa T; Yamauchi K; Shimotohno K
Int J Cancer; 1994 Jun; 57(5):664-70. PubMed ID: 7515022
[TBL] [Abstract][Full Text] [Related]
14. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
[TBL] [Abstract][Full Text] [Related]
15. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
[TBL] [Abstract][Full Text] [Related]
16. Sequences in the hypervariable region 1 of hepatitis C virus show only minimal variability in the presence of antibodies against hypervariable region 1 during acute infection in chimpanzees.
Zhou YH; Sugitani M; Esumi M
Arch Virol; 2002 Oct; 147(10):1955-62. PubMed ID: 12376756
[TBL] [Abstract][Full Text] [Related]
17. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus.
Zhou YH; Moriyama M; Esumi M
Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201
[TBL] [Abstract][Full Text] [Related]
18. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses.
van Doorn LJ; Capriles I; Maertens G; DeLeys R; Murray K; Kos T; Schellekens H; Quint W
J Virol; 1995 Feb; 69(2):773-8. PubMed ID: 7815542
[TBL] [Abstract][Full Text] [Related]
19. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine.
Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595
[TBL] [Abstract][Full Text] [Related]
20. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
Simmonds P; Rose KA; Graham S; Chan SW; McOmish F; Dow BC; Follett EA; Yap PL; Marsden H
J Clin Microbiol; 1993 Jun; 31(6):1493-503. PubMed ID: 7686182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
